Barclays
GHRS icon

Barclays’s GH Research GHRS Stock Holding History

Barclays’s Portfolio GHRS Stock Details GHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$161K Buy
5,977
+1,583
+36% +$33K ﹤0.01% 3829
2026
Q1 		$61.8K Buy
4,394
+2,276
+107% +$34.9K ﹤0.01% 4234
2025
Q4 		$26.9K Buy
2,118
+822
+63% +$11.2K ﹤0.01% 4838
2025
Q3 		$18.5K Buy
+1,296
New +$18.1K ﹤0.01% 4951
2025
Q1 		– Sell
-1,703
Closed -$11.9K – 5362
2024
Q4 		$11.9K Sell
1,703
-4,281
-72% -$34.4K ﹤0.01% 4975
2024
Q3 		$40K Sell
5,984
-13,925
-70% -$143K ﹤0.01% 4793
2024
Q2 		$232K Sell
19,909
-11,591
-37% -$139K ﹤0.01% 3499
2024
Q1 		$336K Hold
31,500
– – ﹤0.01% 3830
2023
Q4 		$183K Sell
31,500
-32,090
-50% -$227K ﹤0.01% 4456
2023
Q3 		$639K Buy
63,590
+31,500
+98% +$364K ﹤0.01% 2640
2023
Q2 		$381K Hold
32,090
– – ﹤0.01% 2919
2023
Q1 		$256K Hold
32,090
– – ﹤0.01% 3659
2022
Q4 		$312K Hold
32,090
– – ﹤0.01% 3600
2022
Q3 		$373K Hold
32,090
– – ﹤0.01% 2862
2022
Q2 		$320K Sell
32,090
-2,002
-6% -$26K ﹤0.01% 3154
2022
Q1 		$624K Buy
+34,092
New +$602K ﹤0.01% 2738

Other funds holding GHRS

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Barclays's GHRS Position: Q2 2026 in Review

Barclays increased its GH Research (GHRS) stake by 36% in Q2 2026, buying an estimated $33K and bringing the position to 5,977 shares worth $161K. The position accounts for ﹤0.01% of the portfolio, ranked #3829.

Barclays first reported a position in GHRS in Q1 2022 and has held it in 16 quarters since. The position peaked at $639K in Q3 2023. 63 funds tracked by Wall St. Rank hold GHRS as of Q2 2026.

  • Barclays held 5,977 shares of GH Research worth $161K as of Q2 2026.
  • Barclays bought 1,583 GH Research shares in Q2 2026, an estimated $33K.
  • GH Research made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3829 holding.
  • Barclays first reported a position in GH Research in Q1 2022 and has held it in 16 quarters since.
  • Barclays's GH Research position peaked at $639K in Q3 2023.
  • 63 funds tracked by Wall St. Rank held GH Research as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.